Moneycontrol PRO
HomeNews

Sars Cov 2

Jump to
  • Rajasthan health officials asked to form response teams, action plan amid pneumonia outbreak in China

    Rajasthan health officials asked to form response teams, action plan amid pneumonia outbreak in China

    In its advisory issued here, the health department asked officials concerned to prepare an action plan for the prevention and treatment of the disease.

  • WHO classifies 'Eris' Covid strain as 'variant of interest’

    WHO classifies 'Eris' Covid strain as 'variant of interest’

    The WHO and its Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) continue to regularly assess the impact of variants on the performance of COVID-19 vaccines to inform decisions on updates to vaccine composition.

  • COVID-19 no longer a global health emergency: WHO

    COVID-19 no longer a global health emergency: WHO

    WHO chief Tedros Adhanom Ghebreyesus has also warned of the ongoing impact of Long Covid, which provokes a long line of often severe and debilitating symptoms that can drag on for months or years.

  • Omicron's XBB most prevalent sub-lineage circulating all over India: INSACOG bulletin

    Omicron's XBB most prevalent sub-lineage circulating all over India: INSACOG bulletin

    According to the bulletin, BA.2.75 and BA.2.10 were also circulating but in lesser extent.

  • 50-70% of those under 19 years globally still susceptible to SARS-CoV-2: Study

    50-70% of those under 19 years globally still susceptible to SARS-CoV-2: Study

    It also found that worldwide seroprevalence estimates varied from 7.3 per cent in the first wave of the COVID-19 pandemic to 37.6 per cent in the fifth wave and 56.6 per cent in the sixth wave.

  • Coronavirus origins: the debate flares up, but the evidence remains weak

    Coronavirus origins: the debate flares up, but the evidence remains weak

    A recent preprint (a study yet to be peer-reviewed) claims to have identified possibly unusual sequence patterns in the SARS-CoV-2 genome.

  • New intranasal anti-viral treatment may block COVID-19 transmission

    New intranasal anti-viral treatment may block COVID-19 transmission

    Existing drugs aimed at treating COVID-19 address symptoms of the virus but do little to quell viral shedding.

  • Tomato flu not linked to SARS CoV 2, monkeypox or dengue, says Health Ministry

    Tomato flu not linked to SARS CoV 2, monkeypox or dengue, says Health Ministry

    The recent outbreak of the disease has been reported from four states in the country  

  • In pics | All you need to know about BCG vaccine for TB that can protect humans from COVID-19

    In pics | All you need to know about BCG vaccine for TB that can protect humans from COVID-19

    As per recent studies, the BCG vaccine -- originally for tuberculosis (TB), can provide protection against COVID-19, and several infections such as leprosy and malaria.

  • Strides Pharma announces results of SARS-CoV-2 vaccine clinical trial in India

    Strides Pharma announces results of SARS-CoV-2 vaccine clinical trial in India

    The vaccine was well tolerated with no significant safety concerns and a seroconversion rate of 91%

  • COVID-19 shots may be required on an annual basis in the future: USFDA

    COVID-19 shots may be required on an annual basis in the future: USFDA

    They also opined that the virus will likely circulate globally, with other prevalent respiratory viruses like influenza. It was also stated by them that this scenario almost certainly necessitates the same level of annual consideration for vaccine composition revisions.

  • Over 2 lakh genome of SARS-CoV-2 sequenced by INSACOG: Govt

    Over 2 lakh genome of SARS-CoV-2 sequenced by INSACOG: Govt

    Responding to a question in Lok Sabha, Minister of State for Science and Technology Jitendra Singh said 17 COVID-19 bio-repositories have been notified by the government.

  • Panacea-govt collaboration for vaccine against future coronaviruses gets major funding boost

    Panacea-govt collaboration for vaccine against future coronaviruses gets major funding boost

    Betacoronaviruses are being seen as a major threat to humanity and the current way of life and public health experts feel that vaccines could be a crucial tool to fight them as they emerge.

  • First biosafety level 3 mobile lab launched in India

    First biosafety level 3 mobile lab launched in India

    The government said that laboratory will be able to access even remote and forested areas where specially trained scientists from the ICMR can investigate outbreaks using samples from humans and animal sources.

  • India’s INSACOG on alert as Deltracon variant now reported from 3 countries

    India’s INSACOG on alert as Deltracon variant now reported from 3 countries

    The first reports of Deltracon emerged from Cyprus earlier this year but were dismissed as result of possible contamination of samples. Scientists around the world, including in India, however are now closely watching whether Deltacron can pose fresh threat.

  • India’s diagnostics industry has seen huge innovations during the COVID pandemic: Mylab MD Hasmukh Rawal

    India’s diagnostics industry has seen huge innovations during the COVID pandemic: Mylab MD Hasmukh Rawal

    From testing to treatment, Pune-based Mylab believes the time has come to adopt an integrated approach and deliver products needed from the patient’s perspective. MD Hasmukh Rawal lays out the company’s plans.

  • Bharat Biotech says Covaxin safe for booster dose against Covid

    Bharat Biotech says Covaxin safe for booster dose against Covid

    Further, reactogenicity after vaccine and placebo was minimal and comparable, and no serious adverse events were reported, the company said referring to the trial results.

  • Breakthrough infections generate strong immunity to COVID-19 variants: Study

    Breakthrough infections generate strong immunity to COVID-19 variants: Study

    The research, published in the Journal of the American Medical Association (JAMA), shows that a breakthrough infection generates a robust immune response against the Delta variant.

  • COVID-19 vaccines effective against most SARS-CoV-2 variants: Study

    COVID-19 vaccines effective against most SARS-CoV-2 variants: Study

    The findings, published in the journal Nature on Tuesday, also show that those infected with the virus prior to vaccination exhibit a more robust immune response to all variants than those who were uninfected and fully vaccinated.

  • Vaccinated against COVID-19, will it be necessary to be re-vaccinated?

    Vaccinated against COVID-19, will it be necessary to be re-vaccinated?

    A vaccine booster is the injection of an additional dose, intended to maintain immune protection against a given pathogen.

  • COVID-19 | Gene editing 'blocks virus transmission' in human cells

    COVID-19 | Gene editing 'blocks virus transmission' in human cells

    Writing in the journal Nature Communications, researchers in Australia said the tool was effective against viral transmissions in lab tests, adding that they hoped to begin animal trials soon.

  • Did coronavirus originate in a Wuhan lab? Clamour grows for China to offer answers

    Did coronavirus originate in a Wuhan lab? Clamour grows for China to offer answers

    Over the past few weeks, statements from the White House and the G7 have spurred renewed interest on how SARS-CoV-2, the virus that causes COVID-19, may have developed. Here's a breakdown of the various theories, including the one that it leaked from a Wuhan lab.

  • COVID-19 update | Delayed report says coronavirus probably came to humans from animals

    COVID-19 update | Delayed report says coronavirus probably came to humans from animals

    Drafted by a team of World Health Organization-appointed international experts and Chinese counterparts, the report has been keenly anticipated ever since investigators left China more than a month ago.

  • How coronavirus may hijack human cells, shows study

    How coronavirus may hijack human cells, shows study

    In the current study, published in the journal Science Signalling, the scientists focussed particularly on short strings of amino acids called short linear motifs (SLiMs), which are involved in transmitting information between the inside and outside of cells.

  • COVID-19 update | Government identifies 10 labs to monitor genomic variations in Sars-Cov-2

    COVID-19 update | Government identifies 10 labs to monitor genomic variations in Sars-Cov-2

    The government will maintain all the genomic sequencing data in its national database at two sites including West Bengal's National Institute of Biomedical Genomics and New Delhi's Institute of Genomics and Integrative Biology.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347